Publications by authors named "Mario L Morieri"

Claim this Profile
J
Joslin Kidney Panel of Circulating Proteins: A Tool for ESKD Risk Discrimination and Individualized Diabetic Kidney Disease Treatment.
Andrzej S Krolewski, Jani K Haukka, Zaipul I Md Dom, Viktor R Curovic, Chunyi Wu, Mario Luca Morieri

Clin J Am Soc Nephrol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stratifying cardiovascular benefits from GLP-1RA: a multisource analysis of patient-level CVOT and real-world data using AI-driven methods.
Mario Luca Morieri, Enrico Longato, Veronica Sciannameo, Emily Donatiello, Paola Berchialla

Cardiovasc Diabetol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease.
Gian Paolo Fadini, Enrico Longato, Mario Luca Morieri, Fabio Broglio, Gianluca Aimaretti

Diabetes Obes Metab· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effects of adding an SGLT-2 inhibitor to insulin therapy in patients with type 1 diabetes. An observational study and systematic review of real-world evidence.
Alberto Maran, Federico Boscari, Carlo Fagarazzi, Maria Cristina Crepaldi, Monica Vedovato, Mario Luca Morieri

J Endocrinol Invest· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early weight loss, diabetes remission and long-term trajectory after diagnosis of type 2 diabetes: a retrospective study.
Mario Luca Morieri, Mauro Rigato, Vera Frison, Michele D'Ambrosio, Giovanni Sartore

Diabetologia· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease.
Mengyao Tang, Mario Luca Morieri, Sahir Kalim, Alessandro Doria

J Am Soc Nephrol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care.
Gian Paolo Fadini, Enrico Longato, Mario Luca Morieri, Enzo Bonora, Agostino Consoli

Diabetologia· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Elusive Nature of ABCC8-related Maturity-Onset Diabetes of the Young (ABCC8-MODY). A Review of the Literature and Case Discussion.
Marella Marassi, Mario Luca Morieri, Viola Sanga, Giulio Ceolotto, Angelo Avogaro

Curr Diab Rep· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of MASLD and MetALD on clinical outcomes: A meta-analysis of preliminary evidence.
Stefano Ciardullo, Alessandro Mantovani, Mario Luca Morieri, Emanuele Muraca, Pietro Invernizzi

Liver Int· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes.
Stefano Ciardullo, Mario Luca Morieri, Giuseppe Daniele, Teresa Vanessa Fiorentino, Teresa Mezza

Acta Diabetol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reporting guidelines for precision medicine research of clinical relevance: the BePRECISE checklist.
Siew S Lim, Zhila Semnani-Azad, Mario L Morieri, Ashley H Ng, Abrar Ahmad

Nat Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk.
Gian Paolo Fadini, Enrico Longato, Mario Luca Morieri, Stefano Del Prato, Angelo Avogaro

Lancet Reg Health Eur· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and risk factors of glomerular hyperfiltration in adults with type 2 diabetes: A population-based study.
Domenico Tricò, Gian Paolo Fadini, Mario Luca Morieri, Riccardo Candido, Olga Eugenia Disoteo

Diabetes Metab Res Rev· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus.
Alessandro Mantovani, Mario Luca Morieri, Raffaella Aldigeri, Luisa Palmisano, Maria Masulli

Diabetes Metab· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysis.
Abrar Ahmad, Lee-Ling Lim, Mario Luca Morieri, Claudia Ha-Ting Tam, Feifei Cheng

Commun Med (Lond)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved prediction of long-term kidney outcomes in people with type 2 diabetes by levels of circulating haematopoietic stem/progenitor cells.
Benedetta Maria Bonora, Mario Luca Morieri, Marella Marassi, Roberta Cappellari, Angelo Avogaro

Diabetologia· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Features, Cardiovascular Risk Profile, and Therapeutic Trajectories of Patients with Type 2 Diabetes Candidate for Oral Semaglutide Therapy in the Italian Specialist Care.
Mario Luca Morieri, Riccardo Candido, Simona Frontoni, Olga Disoteo, Anna Solini

Diabetes Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial on "Genetics And Metabolic Diseases" Special Issue.
Mario Luca Morieri, Hongwen Zhou

Adv Biol (Weinh)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus.
Alessandro Csermely, Alessandro Mantovani, Mario Luca Morieri, Luisa Palmisano, Maria Masulli

Diabetes Metab· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep-learning-based natural-language-processing models to identify cardiovascular disease hospitalisations of patients with diabetes from routine visits' text.
Alessandro Guazzo, Enrico Longato, Gian Paolo Fadini, Mario Luca Morieri, Giovanni Sparacino

Sci Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine.
Deirdre K Tobias, Jordi Merino, Abrar Ahmad, Catherine Aiken, Jamie L Benham, Mario Luca Morieri

Nat Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes.
Alessandra Dei Cas, Raffaella Aldigeri, Alessandro Mantovani, Maria Masulli, Luisa Palmisano, Mario Luca Morieri

J Clin Endocrinol Metab· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision Prognostics for Cardiovascular Disease in Type 2 Diabetes: A Systematic Review and Meta-analysis.
Abrar Ahmad, Lee-Ling Lim, Mario Luca Morieri, Claudia Ha-Ting Tam, Feifei Cheng

medRxiv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus.
Alessandro Mantovani, Mario Luca Morieri, Luisa Palmisano, Maria Masulli, Efisio Cossu

Cardiovasc Diabetol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid kidney function decline and increased risk of heart failure in patients with type 2 diabetes: findings from the ACCORD cohort : Rapid kidney function decline and heart failure in T2D.
Carlos Roberto Bueno Junior, Arjola Bano, Yaling Tang, Xiuqin Sun, Alex Abate, Mario Luca Morieri

Cardiovasc Diabetol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis